Cystic Fibrosis Screen

Additional Tests Offered (Per Consultation)

TURN AROUND TIME

7-10 Calendar Days

TEST INFO

SAMPLE INFO

Test Name
Cystic Fibrosis Screen
Alternate Name(s)
  • CF
Test Description
This test will identify approximately 90% of Cystic Fibrosis (CF) mutations in the Caucasian population, and 97% in the Ashkenazi Jewish population.
CyberLAB Test Info

Test Name

Test #

CYSTIC FIBROSIS SCREEN

24

Method Description
  • Multiplex Polymerase Chain Reaction - Massively Parallel Sequencing
FDA Cleared / Approved
No
CPT Code(s)
  • 81220
STAT Allowed
No
Notes
Setup Sun-Fri AM
Draw Status

Living

Sample Volume
Minimum Sample Volume
  • 3 mL
Preferred Sample Volume
  • 4 mL
Sample Type
Acceptable
  • Saliva
  • Whole Blood Lithium Heparin
  • Whole Blood ACD
Preferred
  • Whole Blood Sodium Heparin
  • Whole Blood EDTA
Sample Stability
  • Ambient - 8 days
  • Frozen - Unacceptable
  • Refrigerated 2-8°C - 8 days
Transport
Refrigerated